Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the appointment of Richard Rodgers, MBA to its board as an independent director. Rodgers brings extensive experience in biopharmaceutical management to his role on the Novavax Board of Directors, a statement said. “Rick’s deep experience in the pharmaceutical industry…